- Home
- CTLP vs AMLX Comparison
CTLP vs AMLX Comparison
Compare CTLP & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- AMLX
- Stock Information
- Founded
- CTLP 1992
- AMLX 2014
- Country
- CTLP United States
- AMLX United States
- Employees
- CTLP N/A
- AMLX N/A
- Industry
- CTLP EDP Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- CTLP Technology
- AMLX Health Care
- Exchange
- CTLP Nasdaq
- AMLX Nasdaq
- Market Cap
- CTLP 797.4M
- AMLX 749.9M
- IPO Year
- CTLP N/A
- AMLX 2022
- Fundamental
- Price
- CTLP $10.66
- AMLX $13.48
- Analyst Decision
- CTLP Hold
- AMLX Strong Buy
- Analyst Count
- CTLP 4
- AMLX 7
- Target Price
- CTLP $12.00
- AMLX $15.14
- AVG Volume (30 Days)
- CTLP 1.7M
- AMLX 2.0M
- Earning Date
- CTLP 11-06-2025
- AMLX 11-06-2025
- Dividend Yield
- CTLP N/A
- AMLX N/A
- EPS Growth
- CTLP 473.33
- AMLX N/A
- EPS
- CTLP 0.86
- AMLX N/A
- Revenue
- CTLP $302,548,000.00
- AMLX N/A
- Revenue This Year
- CTLP $18.25
- AMLX N/A
- Revenue Next Year
- CTLP $12.30
- AMLX N/A
- P/E Ratio
- CTLP $12.38
- AMLX N/A
- Revenue Growth
- CTLP 12.64
- AMLX N/A
- 52 Week Low
- CTLP $7.01
- AMLX $2.60
- 52 Week High
- CTLP $11.36
- AMLX $15.15
- Technical
- Relative Strength Index (RSI)
- CTLP 40.31
- AMLX 61.47
- Support Level
- CTLP $10.55
- AMLX $12.35
- Resistance Level
- CTLP $10.61
- AMLX $13.75
- Average True Range (ATR)
- CTLP 0.05
- AMLX 0.82
- MACD
- CTLP 0.01
- AMLX -0.22
- Stochastic Oscillator
- CTLP 80.00
- AMLX 41.86
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.